Samraat S. Raha
Net Worth
Last updated:
What is Samraat S. Raha net worth?
The estimated net worth of Mr. Samraat S. Raha is at least $9,796,873 as of 31 Mar 2021. He owns shares worth $6,478,253 as insider, has earned $127,500 from insider trading and has received compensation worth at least $3,191,120 in Agilent Technologies, Inc..
What is the salary of Samraat S. Raha?
Mr. Samraat S. Raha salary is $797,780 per year as Senior Vice President and Pres of Diagnostics & Genomics Group in Agilent Technologies, Inc..
How old is Samraat S. Raha?
Mr. Samraat S. Raha is 52 years old, born in 1973.
What stocks does Samraat S. Raha currently own?
As insider, Mr. Samraat S. Raha owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Agilent Technologies, Inc. (A) | Senior Vice President and Pres of Diagnostics & Genomics Group | 53,936 | $120.11 | $6,478,253 |
What does Agilent Technologies, Inc. do?
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Samraat S. Raha insider trading
Agilent Technologies, Inc.
Mr. Samraat S. Raha has made only one insider trade in 2021, according to the Form 4 filled with the SEC. He sold 1,000 units of A stock worth $127,500 on 31 Mar 2021.
As of 31 Mar 2021 he still owns at least 53,936 units of A stock.
Agilent Technologies key executives
Agilent Technologies, Inc. executives and other stock owners filed with the SEC:
- Mr. Jacob Thaysen (50) Senior Vice President and Pres of Life Sciences & Applied Markets Group
- Mr. Michael R. McMullen (64) Chief Executive Officer, Pres & Director
- Mr. Michael Tang (51) Senior Vice President, Gen. Counsel & Sec.
- Mr. Robert W. McMahon (56) Senior Vice President & Chief Financial Officer
- Mr. Samraat S. Raha (52) Senior Vice President and Pres of Diagnostics & Genomics Group